Economic responsibility
Improving worldwide access to healthcare and tackling some of the world’s most devastating and neglected diseases helps give everyone the opportunity to lead a healthy life.
We’re proud that the actions of Johnson & Johnson to expand access to our medicines and focus on addressing diseases that disproportionately impact people in lower- and middle-income countries have ranked the Company second in the 2022 Access to Medicine Index report (updated every 2 years).
We’re proud that the actions of Johnson & Johnson to expand access to our medicines and focus on addressing diseases that disproportionately impact people in lower- and middle-income countries have ranked the Company second in the 2022 Access to Medicine Index report (updated every 2 years).
We never lose sight of the people we serve or the possibilities science provides. We are committed to enabling patient access to transformational medical innovation now and in the future.
Learn how we apply our access and pricing principles to systematically plan for access across our entire portfolio, beginning early in our development process, to ensure that our medicines reach the people who need them most. Novel and inclusive approaches to clinical trials and medicine development, combined with a broad and deep portfolio, ensure value is built into our products for every person treated.